EA201200765A1 - Способ получения полиморфной модификации холиновой соли производного пиримидин-5-илуксусной кислоты - Google Patents
Способ получения полиморфной модификации холиновой соли производного пиримидин-5-илуксусной кислотыInfo
- Publication number
- EA201200765A1 EA201200765A1 EA201200765A EA201200765A EA201200765A1 EA 201200765 A1 EA201200765 A1 EA 201200765A1 EA 201200765 A EA201200765 A EA 201200765A EA 201200765 A EA201200765 A EA 201200765A EA 201200765 A1 EA201200765 A1 EA 201200765A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pyrimidin
- iluxic
- acid
- salt derivative
- polymorphic modification
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
В заявке описан способ получения холиновой соли [4,6-бис(диметиламино)-2-(4-{[4-(трифторметил)бензоил]амино}бензил)пиримидин-5-ил]уксусной кислоты. Предлагаемый в изобретении способ позволяет получать подобную соль в более чистой форме. В заявке описана также более чистая форма холиновой соли [4,6-бис-(диметиламино)-2-(4-{[4-(трифторметил)бензоил]амино}бензил)пиримидин-5-ил]уксусной кислоты.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26387109P | 2009-11-24 | 2009-11-24 | |
PCT/US2010/057312 WO2011066176A1 (en) | 2009-11-24 | 2010-11-19 | Process for preparing a polymorph of the choline salt of a pyrimidin-5-yl acetic acid derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201200765A1 true EA201200765A1 (ru) | 2013-02-28 |
Family
ID=43447007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201200765A EA201200765A1 (ru) | 2009-11-24 | 2010-11-19 | Способ получения полиморфной модификации холиновой соли производного пиримидин-5-илуксусной кислоты |
Country Status (15)
Country | Link |
---|---|
US (1) | US20110294828A1 (ru) |
EP (1) | EP2504319A1 (ru) |
JP (1) | JP2013512242A (ru) |
KR (1) | KR20120101399A (ru) |
CN (1) | CN102666499A (ru) |
AR (1) | AR079128A1 (ru) |
AU (1) | AU2010324980A1 (ru) |
BR (1) | BR112012012384A2 (ru) |
CA (1) | CA2781610A1 (ru) |
CL (1) | CL2012001170A1 (ru) |
EA (1) | EA201200765A1 (ru) |
IL (1) | IL218990A0 (ru) |
MX (1) | MX2012006003A (ru) |
TW (1) | TW201200501A (ru) |
WO (1) | WO2011066176A1 (ru) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
FR2585563B1 (fr) | 1985-07-30 | 1993-11-12 | Glaxo Group Ltd | Dispositif pour administrer des medicaments a des patients |
SE453566B (sv) | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
PT1471057E (pt) * | 2003-04-25 | 2006-05-31 | Actimis Pharmaceuticals Inc | Derivados de acido pirimidinilacetico uteis para o tratamento de doencas mediadas por crth2 |
EP2051943A4 (en) | 2006-08-03 | 2011-03-23 | Bromine Compounds Ltd | METHOD, DEVICE AND SYSTEM FOR WATER TREATMENT |
UA101326C2 (en) * | 2007-06-21 | 2013-03-25 | Актимис Фармасьютикалз, Инк. | Amine salts of crth2 antagonist |
JP2010530425A (ja) | 2007-06-21 | 2010-09-09 | アクチミス ファーマシューティカルズ インコーポレーテッド | Crth2アンタゴニストの粒子 |
-
2010
- 2010-11-19 CA CA2781610A patent/CA2781610A1/en not_active Abandoned
- 2010-11-19 US US12/950,099 patent/US20110294828A1/en not_active Abandoned
- 2010-11-19 EA EA201200765A patent/EA201200765A1/ru unknown
- 2010-11-19 JP JP2012541119A patent/JP2013512242A/ja active Pending
- 2010-11-19 MX MX2012006003A patent/MX2012006003A/es not_active Application Discontinuation
- 2010-11-19 AU AU2010324980A patent/AU2010324980A1/en not_active Abandoned
- 2010-11-19 CN CN2010800528826A patent/CN102666499A/zh active Pending
- 2010-11-19 BR BR112012012384A patent/BR112012012384A2/pt not_active IP Right Cessation
- 2010-11-19 WO PCT/US2010/057312 patent/WO2011066176A1/en active Application Filing
- 2010-11-19 EP EP10782506A patent/EP2504319A1/en not_active Withdrawn
- 2010-11-19 KR KR1020127013274A patent/KR20120101399A/ko not_active Application Discontinuation
- 2010-11-23 TW TW099140438A patent/TW201200501A/zh unknown
- 2010-11-23 AR ARP100104319A patent/AR079128A1/es unknown
-
2012
- 2012-04-02 IL IL218990A patent/IL218990A0/en unknown
- 2012-05-04 CL CL2012001170A patent/CL2012001170A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2012001170A1 (es) | 2012-10-12 |
BR112012012384A2 (pt) | 2016-03-22 |
US20110294828A1 (en) | 2011-12-01 |
KR20120101399A (ko) | 2012-09-13 |
EP2504319A1 (en) | 2012-10-03 |
WO2011066176A1 (en) | 2011-06-03 |
AR079128A1 (es) | 2011-12-28 |
CN102666499A (zh) | 2012-09-12 |
TW201200501A (en) | 2012-01-01 |
MX2012006003A (es) | 2012-06-19 |
CA2781610A1 (en) | 2011-06-03 |
IL218990A0 (en) | 2012-06-28 |
JP2013512242A (ja) | 2013-04-11 |
AU2010324980A1 (en) | 2012-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL229395A0 (en) | Adjusted release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-4)-5-n-methyl-h1 imidazol-1-yl)-3-(trifluoromethyl)phenyl] Benzamide is dissolved using organic acids | |
RS54653B1 (en) | 2- (2,4,5-SUBSTITUTED-ANILINO) PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR CANCER TREATMENT | |
EA200702614A1 (ru) | Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот | |
CY1115944T1 (el) | Παραγωγα 4-(ινδολ-7-υλοκαρβονυλαμινομεθυλο)κυκλοεξανοκαρβοξυλικου οξεος ως ανταγωνιστες του ερ4 υποδοχεα χρησιμοι για την αντιμετωπιση χρονιας νεφρικης ανεπαρκειας ή διαβητικης νεφροπαθειας | |
UA111640C2 (uk) | ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2 | |
ECSP10010582A (es) | Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer | |
UA84462C2 (ru) | Полиморфные модификации кислотно-аддитивных солей иматиниба с метансульфоновой кислотой | |
CL2007002949A1 (es) | Forma cristalina del compuesto 2-cloro-5-(3,6-dihidro-3-metil-2,6-dioxo-4-(trifluorometil)-1-(2h)-pirimidinil)-4-fluoro-n-((metil(1-metiletil)amino)sulfonil)benzamida; proceso para la preparacion de dicha forma cristalina; composicion fitoprotectora; | |
DK3683209T3 (da) | Fremgangsmåde til fremstilling af [(5-(3-chlorphenyl)-3-hydroxypyridin-2-carbonyl)-amino]eddikesyre fra 5-((3-chlorphenyl)-3-chlor-pyridin-2-yl)-nitril og fremgangsmåde til fremstilling af 5-((halogenphenyl)-3-halogen-pyridin-2-yl)-nitrilderivater | |
WO2012044727A3 (en) | Manufacturing process for pyrimidine derivatives | |
EA201101301A1 (ru) | Натриевая соль 5-циклопропил-2-{[2-(2,6-дифторфенил)пиримидин-5-ил]амино}бензойной кислоты в качестве ингибиторов dhodh | |
BRPI0905928A2 (pt) | "método de produção de ácido lático" | |
HK1202237A1 (zh) | -二氯- -苯並 咪唑- -基 -吡唑- -羧酸的葡甲胺鹽製劑 | |
CR20140462A (es) | Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil]etil} amino) -1-hidroxietil]-8-hidroquinolin-2(1h)-ona | |
ECSP10010597A (es) | Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas | |
UA104420C2 (ru) | Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств | |
SG10201902903RA (en) | Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine | |
BRPI0913644A2 (pt) | processo para a prepração de derivados de pirimidina substituída. | |
CU20110108A7 (es) | [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos | |
MX2010009876A (es) | Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente. | |
WO2014128719A3 (en) | Processes for the preparation of bispyribac sodium and intermediates thereof | |
EA201200765A1 (ru) | Способ получения полиморфной модификации холиновой соли производного пиримидин-5-илуксусной кислоты | |
WO2013002660A3 (en) | Process | |
MX2011013149A (es) | Acido (s)-2-bencil-3-((3r,4r)-4 - (3 - carbamoilfenil) -3,4-dimetilpiperidinil) propanoico y sales delmismo como antagonistas de receptores opioides. | |
WO2012011129A3 (en) | Novel polymorph of bis[(e)-7-[4-(4-fluorophenyl)-6-iso-propyl-2-[methyl (methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid] calcium salt |